# Inogen Inc — Hazardous Materials Safety Interpretation

**Citation:** 04-0053  
**Type / status:** guidance / guidance  
**Agency:** Pipeline and Hazardous Materials Safety Administration  
**Effective:** Not stated  
**Published:** 2004-03-24

04-0053 response to Inogen Inc concerning 173.115.

## Document text

<<<PAGE 1>>>

U.S. Department
of Transportation
400 Seventh St., S.W.
Research and
Washington, D.C. 20590
Special Programs
Administration
MAR 2 4 2004
Mr. Robert S. Fary
Inogen Inc.
Ref. No. 04-0053
Vice President of Sales
120 Cremona Drive, Suite B
Goleta, CA 93117
Dear Mr. Fary:
This is in response to your letter dated March 10, 2004, regarding the applicability of the Department
of Transportation's Hazardous Materials Regulations (HMR; 49 CFR Parts 171-180) to a device that
your company calls the Inogen One portable oxygen concentrator.
The Inogen One portable oxygen concentrator is a device which separates oxygen from room air for
delivery to patients who require supplemental oxygen therapy. It can be powered by multiple power
sources, including a 12 cell rechargeable lithium ion battery, an AC power pack, and an automobile
cigarette lighter adapter. The total equivalent lithium content of the battery pack is 7.92 grams and each
cell of the battery pack has an equivalent lithium content of 0.66 grams. The process by which oxygen
is separated is called pressure swing adsorption. This process utilizes a small air compressor, valves,
and controlling electronics to pass air across a material called a molecular sieve. The material acts as a
filter to nitrogen and passes the oxygen to the patient. The operating pressure of this device is
approximately 39 psia. The oxygen concentrator contains no other hazardous material that is subject to
the HMR.
Based on the information above, the Inogen One portable oxygen concentrator is not subject to the
HMR because: (1) the pressure of the oxygen in the device never exceeds 40.6 psia at 68 °F; (2) the
lithium ion battery used to operate the device is excepted from the HMR; and (3) the portable oxygen
concentrator contains no other material subject to the HMR. Though the lithium ion battery is excepted
rbidden for transportation unless it is packaged in a manner to preclude it from creating sparks (
om the hivik it must satisty the requirements of § 173.21(c) which states that an electrical device
generating a dangerous quantity of heat (for example, by the effective insulation of exposed terminals).
I hope this satisfies your request.
Sincerely,
Elean 7: Marzullo
Edward T. Mazzullo
Director, Office of Hazardous
Materials Standards
173.115
040053

<<<PAGE 2>>>

Grate
3173.115
Denfinitions
John A. Gale
Transportation Regulations Specialist
04-0053
U.S Department of Transportation
400 Seventh Street S.W.
Washington, DC 20590-0001
March 10, 2004.
Dear John,
excited about the changes that are coming that will result in increased access and
Once again, many thanks for allowing us to visit and present the Inogen One. I am
convenience for oxygen users who travel.
standard. I am happy to say that we are within the guidelines stated in the regulation.
I have attached the information you requested relative to the battery and the current
I respectfully request a letter from you that states that you have found the Inogen One to
be safe and non-hazardous for use on commercial aircraft. Please e-mail the letter to me
at isfary@inogen.net.
Please do not hesitate to call me with any questions or issues that may arise.
Best Regards,
Robert S. Fary
Vice President of Sales
Inogen Corporation
120 Cremona Drive, Suite B
Goleta, CA 93117
805-562-0512
rsfary@inogen.net

<<<PAGE 3>>>

1. In response to questions regarding 49 CFR 173.115 (Definition of a Flammable Gas):
The regulations suggest that oxygen produced by the Inogen One oxygen
concentrator should not be recognized as a "flammable gas" as the maximum
pressure exerted within the product packaging is 39psia or less (depending o1
perating mode) at 20oC (and 1 bar ambient pressure), and is therefore less thar
the 40.6psia specified in 49CFR 173-115 paragraph (b) (1).
2. In response to questions regarding 49 CFR 173.185 (Lithium Batteries and Cells):
The Inogen One battery pack contains 12 cells of the 2.2Ah 18650 cell type.
Lithium Content of 7.92g.
Each cell has an Equivalent Lithium Content of 0.66g*, for a total Equivalent
Because (a) there is less than 1.5g of lithium per cell, (b) less than 8.0g total
lithium, and (c) less than or equal to 12 cells per battery pack, an individual pack
prevent short circuits.
is not a Class 9 material. Each pack is strongly packaged and packed in a way to
Nonetheless, Inogen intends to and certifies that it will (1) label all of its batteries
as containing lithium; (2) label any packaging for the battery to indicate that they
contain lithium batteries, (3) qualify the battery through UN tests (T1-T8).
"Equivalent Lithium Content is measured as 0.3 times the rated capacity (ampere hours (Ah)) of
the battery equals the sum of the grams of lithium equivalent content contained in the component
the cell in Ampere-hours, with the results expressed in grams. The lithium-equivalent content of
cells of the battery. (Example: an 18650 Li-ion cell with 1.8Ah of rated capacity would contain
of Lithium Transportation Regulations - as of May 2003), Panasonic Industrial Company."
0.54g of lithium (1.8 x 0.3) and 6 of these cells in a pack would equal 3.24g). Source: "Overview
3. Additionally, 14 CFR 125.219 and 135.91 were mentioned. As both of these apply to
rules governing use of devices on aircraft, and not the devices themselves, we feel they
are not germane to this discussion.

## Provenance

- Official: Yes
- Source: <https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2004/040053.pdf>
- Source ID: `phmsa`
- SHA-256: `d9dce9d925c7b1620d1a41e0849bb9c411fbc6443d5f3c22ecfd4fd2e8e6c27b`
- Retrieved: 2026-08-20T00:59:31.977Z
- Exported: 2026-08-25T07:07:16.652Z
- Document slug: `phmsa-interpretation-04-0053`

### Source metadata

```json
{
  "materialSubtype": "interpretation",
  "interpretationArea": "hazardous_materials",
  "representation": "full_text_from_official_pdf",
  "companies": [
    "Inogen Inc"
  ],
  "individuals": [
    "Mr. Robert S. Fary"
  ],
  "refIds": [
    "04-0053"
  ],
  "catalogDates": [
    "2004-03-24"
  ],
  "catalogParts": [
    173
  ],
  "catalogRowCount": 1,
  "sourceRecordUrls": [
    "https://www.phmsa.dot.gov/node/62041"
  ],
  "linkedAttachmentUrls": [],
  "unavailableResponseUrls": [],
  "duplicateRepresentationUrls": [],
  "citedSections": [
    "173.115",
    "40.6",
    "173.21(c)",
    "173.185"
  ],
  "catalogPageUrls": [
    "https://www.phmsa.dot.gov/regulations/title49/section/173115"
  ],
  "pdfUrls": [
    "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2004/040053.pdf"
  ],
  "representations": [
    {
      "viewUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2004/040053.pdf",
      "detailUrl": null,
      "detailHtmlPath": null,
      "pdfUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretation%20Files/2004/040053.pdf",
      "pdfArtifactPath": "data/sources/phmsa-interpretations/04-0053-4c6ddd1c63.pdf",
      "pdfArtifactSha256": "37bb1afe66c06f62ddf1f7bd7eec84e472258a08b9f99833076f3449c8cc04fd",
      "extractedTextPath": "data/sources/phmsa-interpretations/04-0053-4c6ddd1c63.v2.txt",
      "extractedTextSha256": "457cc7f6693991fa58f68c3080c9213e0e98b1ad1b8224f4e767ac79992df10e",
      "pageCount": 3,
      "extractionVersion": 2
    }
  ],
  "caveat": "Interpretations apply regulations to the facts presented and do not create independently enforceable requirements.",
  "jurisdiction": "US"
}
```
